Recap: LogicBio Therapeutics Q2 Earnings

LogicBio Therapeutics LOGC reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

LogicBio Therapeutics beat estimated earnings by 37.5%, reporting an EPS of $-0.15 versus an estimate of $-0.24.

Revenue was up $2.40 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 1.21% drop in the share price the next day.

Here's a look at LogicBio Therapeutics's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.28	-0.34	-0.30	-0.24
EPS Actual	-0.20	-0.28	-0.31	-0.33
Revenue Estimate	900K	1.45M	5.45M	6.97M
Revenue Actual	2.82M	2.03M	2.12M	802K

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for LogicBio Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar